These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 8461303

  • 1. Design of a linker for trivalent thrombin inhibitors: interaction of the main chain of the linker with thrombin.
    Szewczuk Z, Gibbs BF, Yue SY, Purisima E, Zdanov A, Cygler M, Konishi Y.
    Biochemistry; 1993 Apr 06; 32(13):3396-404. PubMed ID: 8461303
    [Abstract] [Full Text] [Related]

  • 2. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
    Tsuda Y, Cygler M, Gibbs BF, Pedyczak A, Féthière J, Yue SY, Konishi Y.
    Biochemistry; 1994 Dec 06; 33(48):14443-51. PubMed ID: 7981204
    [Abstract] [Full Text] [Related]

  • 3. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
    Yue SY, Konishi Y.
    Drug Des Discov; 1994 Jul 06; 12(1):1-17. PubMed ID: 7578804
    [Abstract] [Full Text] [Related]

  • 4. Bifunctional thrombin inhibitors based on the sequence of hirudin45-65.
    DiMaio J, Gibbs B, Munn D, Lefebvre J, Ni F, Konishi Y.
    J Biol Chem; 1990 Dec 15; 265(35):21698-703. PubMed ID: 2254323
    [Abstract] [Full Text] [Related]

  • 5. Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH59 side chain of the inhibitor.
    Tsuda Y, Szewczuk Z, Wang J, Yue SY, Purisima E, Konishi Y.
    Biochemistry; 1995 Jul 11; 34(27):8708-14. PubMed ID: 7612610
    [Abstract] [Full Text] [Related]

  • 6. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E, Elgendy S, Goodwin CA, Green D, Scully MF, Kakkar VV, Freyssinet JM, Dodson G, Deadman JJ.
    Biochemistry; 1998 Oct 13; 37(41):14420-7. PubMed ID: 9772168
    [Abstract] [Full Text] [Related]

  • 7. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
    DiMaio J, Ni F, Gibbs B, Konishi Y.
    FEBS Lett; 1991 Apr 22; 282(1):47-52. PubMed ID: 2026264
    [Abstract] [Full Text] [Related]

  • 8. Chemical compensation in macromolecular bridge-binding to thrombin.
    Hopfner KP, Ayala Y, Szewczuk Z, Konishi Y, Di Cera E.
    Biochemistry; 1993 Mar 30; 32(12):2947-53. PubMed ID: 8457559
    [Abstract] [Full Text] [Related]

  • 9. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ, Purisima E, Tsuda Y, Sulea T, Pedyczak A, Féthière J, Cygler M, Konishi Y.
    Biochemistry; 1997 Nov 04; 36(44):13494-502. PubMed ID: 9354617
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
    Krishnan R, Tulinsky A, Vlasuk GP, Pearson D, Vallar P, Bergum P, Brunck TK, Ripka WC.
    Protein Sci; 1996 Mar 04; 5(3):422-33. PubMed ID: 8868478
    [Abstract] [Full Text] [Related]

  • 11. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
    Shabareesh P, Kaur KJ.
    Chem Biol Drug Des; 2016 Jul 04; 88(1):129-41. PubMed ID: 26850929
    [Abstract] [Full Text] [Related]

  • 12. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ, Sivaraman J, Li Y, Cygler M, Konishi Y.
    Biochemistry; 2000 Mar 07; 39(9):2384-91. PubMed ID: 10694407
    [Abstract] [Full Text] [Related]

  • 13. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
    Zdanov A, Wu S, DiMaio J, Konishi Y, Li Y, Wu X, Edwards BF, Martin PD, Cygler M.
    Proteins; 1993 Nov 07; 17(3):252-65. PubMed ID: 8272424
    [Abstract] [Full Text] [Related]

  • 14. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
    Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW.
    Biochemistry; 1990 Jul 31; 29(30):7095-101. PubMed ID: 2223763
    [Abstract] [Full Text] [Related]

  • 15. Rational design of hirulog-type inhibitors of thrombin.
    Egner U, Hoyer GA, Schleuning WD.
    J Comput Aided Mol Des; 1994 Oct 31; 8(5):479-90. PubMed ID: 7876896
    [Abstract] [Full Text] [Related]

  • 16. Design and evaluation of novel bivalent thrombin inhibitors based on amidinophenylalanines.
    Steinmetzer T, Renatus M, Künzel S, Eichinger A, Bode W, Wikström P, Hauptmann J, Stürzebecher J.
    Eur J Biochem; 1999 Oct 31; 265(2):598-605. PubMed ID: 10504391
    [Abstract] [Full Text] [Related]

  • 17. Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.
    Szewczuk Z, Gibbs BF, Yue SY, Purisima EO, Konishi Y.
    Biochemistry; 1992 Sep 29; 31(38):9132-40. PubMed ID: 1390700
    [Abstract] [Full Text] [Related]

  • 18. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
    Féthière J, Tsuda Y, Coulombe R, Konishi Y, Cygler M.
    Protein Sci; 1996 Jun 29; 5(6):1174-83. PubMed ID: 8762149
    [Abstract] [Full Text] [Related]

  • 19. A strong thrombin-inhibitory prourokinase derivative with sequence elements from hirudin and the human thrombin receptor.
    Wnendt S, Janocha E, Steffens GJ, Strassburger W.
    Protein Eng; 1997 Feb 29; 10(2):169-73. PubMed ID: 9089816
    [Abstract] [Full Text] [Related]

  • 20. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
    De Simone G, Lombardi A, Galdiero S, Nastri F, Della Morte R, Staiano N, Pedone C, Bolognesi M, Pavone V.
    Protein Sci; 1998 Feb 29; 7(2):243-53. PubMed ID: 9521099
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.